about
Chemokine (C-C motif) ligand 12CD14 antigenTransforming growth factor, beta 1Myeloid differentiation primary response gene 88Interleukin 18Lipopolysaccharide binding proteinToll-like receptor 4Lymphocyte antigen 96Interferon regulatory factor 3Chemokine (C-C motif) ligand 5Interleukin 1 betaMitogen-activated protein kinase 1Platelet-activating factor receptorNuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alphaMitogen-activated protein kinase 14Nitric oxide synthase 3, endothelial cellMitogen-activated protein kinase 3LYN proto-oncogene, Src family tyrosine kinaseTransforming growth factor beta 1Scavenger receptor class B member 1Protein kinase C epsilonMetadherinReceptor interacting serine/threonine kinase 2CD6 moleculeHCK proto-oncogene, Src family tyrosine kinaseProtein tyrosine phosphatase non-receptor type 22AKT serine/threonine kinase 1B cell CLL/lymphoma 10Interleukin 1 receptor associated kinase 2Toll like receptor adaptor molecule 1Interleukin 1 receptor associated kinase 1Tumor necrosis factorSignal transducer and activator of transcription 1MALT1 paracaspaseProtein kinase C, epsilonToll-like receptor adaptor molecule 1CD6 antigenChemokine (C-C motif) ligand 3Thymoma viral proto-oncogene 1B cell leukemia/lymphoma 10
P682
Astrocyte elevated gene-1 (AEG-1) is induced by lipopolysaccharide as toll-like receptor 4 (TLR4) ligand and regulates TLR4 signallingSignal transduction by the lipopolysaccharide receptor, Toll-like receptor-4Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4.
P921
Q14885647-FCF61C37-7844-4AA3-8BAC-CDCD32F8A0D0Q14887528-B541B5BF-8D91-4471-B157-1485B6DA35D3Q14887528-CF299084-C1C2-400C-94F0-6EBF37D8B77DQ14904616-A4A751FC-1220-4B08-AE34-07B2A9371149Q14905922-C946A547-F148-4946-B336-326D2F0AF00FQ14907191-2C12B769-D306-4A19-A5BC-63E1B2F8868AQ14907580-F862BA75-20E0-472C-BEF9-CC95425422F3Q14914104-F66DA24D-9AA1-49C4-A412-E5DF4D668887Q14914331-BEF26300-8A81-47E1-8CF8-30EDCBA45A23Q14914341-3DD2AD7D-2554-434F-A8BA-D4B54CD8C85AQ14916107-2F828C5A-1D55-4BA9-BA71-0F70931701A3Q14916107-727FF8C8-6CFC-4C89-9CC0-20D17BEDB139Q14916414-496BAAC1-C85E-4095-BD6E-05026C2BBE66Q15317763-F0E77678-B393-46BB-ABA9-F5AD0F167123Q15320076-E02ED4CB-3044-4749-BE8B-00A47621BEFBQ15325126-82EF0D05-F418-44BA-B7B1-F13DF5F34C2EQ15326939-0EC07C1A-64A9-4CAE-A755-5A407D6648BBQ15328616-6496FD25-31CC-4E41-8FAF-098FF7E80547Q15328869-1E175DD5-E18B-45EB-B4C8-2480A9F838A3Q15331919-C46334A9-DB3E-4033-BDF3-AB5ABB1A85EEQ2062543-028F5DC5-391A-45D8-ADF9-1BE5FB6F67D8Q21108841-97F8417E-78A0-43B7-9938-33A2310DB9BBQ21109298-E5F33F33-CA92-4EF3-99E4-5F8A5DB3A19CQ21111259-E2965DF4-6A30-4CF2-AB76-8A8A49CFADE8Q21111679-76859C7D-E255-46BC-9F1B-F2DA8807CE59Q21113034-45D6D01E-1B48-4BEA-83F8-94CFEC39C2A1Q21113798-C67D6B93-AF01-4451-9E86-2D1B043162CBQ21114040-DD7C2AA0-E71E-4777-8032-D38D26117C8BQ21114990-518F4F18-AB57-4723-8D18-41CDD238A5B1Q21116488-9F6A0A55-98E5-4A0A-A066-B353946DBB6DQ21116618-50869C06-696D-4B0B-A29E-2EF5DA66C2C3Q21127355-B221C1E3-8416-4893-8110-EA7A6E789D86Q21173372-290058FD-C95F-4E5C-9C04-A9C8B728A008Q21173843-3DD0E8BF-46D4-4564-902C-3E2C15546C26Q21436490-B4C7ACB4-8203-4C9A-985F-4AA2B74FA120Q21436535-D10920F2-3CB3-45BC-AD05-4D0A08238808Q21491045-5362EF46-6BEB-4833-ADD2-57A018A7E7FAQ21494909-4107B232-9B3E-4C2E-9A03-30B937671795Q21495014-CB37F437-D40D-40E6-84EC-23B20601C438Q21496221-619F1EA4-3F21-47B9-AF21-91FBCC89125E
P682
description
A series of molecular signals ...... ysaccharides are major compone
@en
biologisch proces
@nl
name
lipopolysaccharide-mediated signaling pathway
@en
type
label
lipopolysaccharide-mediated signaling pathway
@en
altLabel
GO:0031663
@en
LPS-mediated signaling pathway
@en
lipopolysaccharide-mediated signalling pathway
@en
prefLabel
lipopolysaccharide-mediated signaling pathway
@en
P2888
P686
GO:0031663